Novavax Inc
NVAXBuild a strategy around NVAX
Novavax Inc AI Insights
Informational only. Not investment advice.Snapshot
- Negative equity (-156.7M) with 251M debt creates structural insolvency risk despite 341.7M TTM net income turnaround.[Common Stockholders Equity]
- FCF of -384.7M TTM vs +341.7M net income - cash burn contradicts reported profitability, 208M receivables increase suspicious.[Free Cash Flow]
- Gross margin 91.8% TTM (vs 54.7% median) with operating margin 38% signals extraordinary unit economics if sustainable.[Gross Margin]
Watch Triggers
- Cash and Equivalents: Falls below 150M or equity raise announced — At -385M FCF, sub-150M cash = <5 months runway, forcing dilutive financing
- Accounts Receivable: Continues rising or write-offs exceed 50M quarterly — 208M receivables spike on declining revenue suggests revenue quality issues
- Free Cash Flow: Turns positive or burn rate exceeds -100M quarterly — FCF-to-net income gap (-385M vs +342M) must close to validate profitability
Bull Case
P/E of 2.8x vs industry median 20.2x - if earnings quality holds, extreme undervaluation exists with 7x upside to median.
91.8% gross margin with 38% operating margin demonstrates platform leverage - R&D 370.8M (35% of revenue) could scale.
Bear Case
Negative equity (-156.7M) + negative FCF (-384.7M) = dilution or bankruptcy inevitable. 268M cash lasts <9 months at burn rate.
Revenue collapsed 52% over 3Y, 15% over 5Y - vaccine demand fading. 208M receivables spike + 97M write-off signals collection crisis.
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage NVAX's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Cash runway crisis likely within 12 months without equity raise or partner funding
- 268M cash vs -385M annual FCF burn rate
- Negative equity blocks traditional debt financing
- No stock issuance in period suggests limited options
Profitability sustainability questionable - receivables spike suggests revenue recognition timing issues
- 208M receivables increase on 1.1B revenue (19% of sales)
- 97M write-off indicates collection problems
- Revenue down 52% 3Y CAGR despite profit surge
Valuation Context
Caveats
NVAX Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$1.48B | — | ||
$1.55B | — | ||
0.00 | — | ||
$596.34M | -50.9% | — | |
$-0.56 | — | ||
3.30% | -30.6% | — | |
-14.7% | -54.1% | — | |
$-97.62M | — | ||
0% | — | ||
Beta 5Y (Monthly) | unknown | — |
NVAX Dividend History
NVAX Stock Splits
NVAX SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
05/06/26 | 03/31/26 | 10-Q | |
02/26/26 | 12/31/25 | Unknown | |
11/06/25 | 09/30/25 | 10-Q | |
08/06/25 | 06/30/25 | 10-Q | |
05/08/25 | 03/31/25 | 10-Q | |
02/27/25 | 12/31/24 | 10-K | |
11/12/24 | 09/30/24 | 10-Q | |
08/08/24 | 06/30/24 | 10-Q | |
05/10/24 | 03/31/24 | 10-Q | |
02/28/24 | 12/31/23 | 10-K | |
11/09/23 | 09/30/23 | 10-Q | |
08/08/23 | 06/30/23 | 10-Q | |
05/09/23 | 03/31/23 | 10-Q | |
02/28/23 | 12/31/22 | 10-K | |
11/09/22 | 09/30/22 | 10-Q | |
08/09/22 | 06/30/22 | 10-Q | |
05/10/22 | 03/31/22 | 10-Q | |
03/01/22 | 12/31/21 | 10-K | |
11/05/21 | 09/30/21 | 10-Q | |
08/05/21 | 06/30/21 | 10-Q | |
05/10/21 | 03/31/21 | 10-Q | |
03/01/21 | 12/31/20 | 10-K | |
11/10/20 | 09/30/20 | 10-Q | |
08/10/20 | 06/30/20 | 10-Q | |
05/11/20 | 03/31/20 | 10-Q | |
03/11/20 | 12/31/19 | 10-K | |
11/07/19 | 09/30/19 | 10-Q | |
08/07/19 | 06/30/19 | 10-Q | |
05/02/19 | 03/31/19 | 10-Q | |
03/18/19 | 12/31/18 | 10-K | |
11/07/18 | 09/30/18 | 10-Q | |
08/08/18 | 06/30/18 | 10-Q | |
05/09/18 | 03/31/18 | 10-Q | |
03/14/18 | 12/31/17 | 10-K | |
11/07/17 | 09/30/17 | 10-Q | |
08/08/17 | 06/30/17 | 10-Q | |
05/08/17 | 03/31/17 | 10-Q | |
02/27/17 | 12/31/16 | 10-K | |
11/09/16 | 09/30/16 | 10-Q | |
08/09/16 | 06/30/16 | 10-Q | |
05/05/16 | 03/31/16 | 10-Q | |
02/29/16 | 12/31/15 | 10-K | |
11/09/15 | 09/30/15 | 10-Q | |
08/10/15 | 06/30/15 | 10-Q | |
05/07/15 | 03/31/15 | 10-Q | |
02/27/15 | 12/31/14 | 10-K | |
11/06/14 | 09/30/14 | 10-Q | |
08/07/14 | 06/30/14 | 10-Q | |
05/08/14 | 03/31/14 | 10-Q | |
03/12/14 | 12/31/13 | 10-K | |
11/12/13 | 09/30/13 | 10-Q | |
08/08/13 | 06/30/13 | 10-Q | |
05/09/13 | 03/31/13 | 10-Q | |
03/12/13 | 12/31/12 | 10-K | |
11/09/12 | 09/30/12 | 10-Q | |
08/09/12 | 06/30/12 | 10-Q | |
05/09/12 | 03/31/12 | 10-Q | |
03/14/12 | 12/31/11 | 10-K | |
11/08/11 | 09/30/11 | 10-Q | |
08/09/11 | 06/30/11 | 10-Q | |
05/10/11 | 03/31/11 | 10-Q | |
03/28/11 | 12/31/10 | 10-K | |
11/08/10 | 09/30/10 | 10-Q | |
08/06/10 | 06/30/10 | 10-Q | |
05/10/10 | 03/31/10 | 10-Q | |
03/16/10 | 12/31/09 | 10-K | |
11/09/09 | 09/30/09 | 10-Q | |
08/10/09 | 06/30/09 | 10-Q | |
05/11/09 | 03/31/09 | 10-Q | |
03/31/09 | 12/31/08 | 10-K | |
11/10/08 | 09/30/08 | 10-Q | |
08/11/08 | 06/30/08 | 10-Q | |
05/12/08 | 03/30/08 | Unknown | -- |
03/17/08 | 12/31/07 | 10-K | |
11/09/07 | 09/30/07 | 10-Q | |
08/09/07 | 06/30/07 | 10-Q | |
05/10/07 | 03/31/07 | 8-K | |
03/16/07 | 12/31/06 | 10-K | |
11/14/06 | 09/30/06 | 10-Q | |
08/14/06 | 06/30/06 | 10-Q | |
05/15/06 | 03/30/06 | Unknown | -- |
03/06/06 | 12/31/05 | 10-K | |
11/08/05 | 09/30/05 | 10-Q | |
08/09/05 | 06/30/05 | 8-K | |
05/10/05 | 03/30/05 | Unknown | -- |
03/15/05 | 12/31/04 | 10-K | |
11/08/04 | 09/30/04 | 10-Q | |
08/09/04 | 06/30/04 | 10-Q | |
05/07/04 | 03/30/04 | Unknown | -- |
03/15/04 | 12/31/03 | 10-K | |
11/12/03 | 09/30/03 | 10-Q | |
08/13/03 | 06/30/03 | 10-Q | |
05/15/03 | 03/30/03 | Unknown | -- |
03/28/03 | 12/31/02 | 10-K | |
11/14/02 | 09/30/02 | 10-Q | |
08/14/02 | 06/30/02 | 10-Q | |
05/15/02 | 03/30/02 | Unknown | -- |
03/15/02 | 12/31/01 | 10-K | |
11/13/01 | 09/30/01 | 10-Q | |
08/13/01 | 06/30/01 | 10-Q | |
05/15/01 | 03/30/01 | Unknown | -- |
03/29/01 | 12/31/00 | 4 | |
11/13/00 | 09/30/00 | 10-Q | |
08/14/00 | 06/30/00 | 10-Q | |
05/12/00 | 03/30/00 | Unknown | -- |